- Report
- February 2022
- 80 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Report
- November 2021
- 70 Pages
Global
From €3121EUR$3,500USD£2,717GBP
- Drug Pipelines
- March 2021
Global
From €2229EUR$2,500USD£1,941GBP
- Drug Pipelines
- March 2021
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- November 2020
- 93 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- November 2020
- 65 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- November 2020
- 114 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- October 2020
- 187 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- October 2020
- 375 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- October 2020
- 773 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- September 2020
- 68 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- September 2020
- 96 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- September 2020
- 737 Pages
Global
From €2229EUR$2,500USD£1,941GBP
- Drug Pipelines
- August 2020
- 384 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- August 2020
- 123 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- July 2020
- 75 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- July 2020
- 96 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- July 2020
- 152 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- July 2020
- 197 Pages
Global
From €1783EUR$2,000USD£1,553GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more